Associated systemic and ocular disorders in patients with congenital unilateral cataracts: the Infant Aphakia Treatment Study experience.

PurposeFive-year prospective data on children enrolled in the Infant Aphakia Treatment Study (IATS) provided an opportunity to explore ocular and systemic associations in patients with a unilateral congenital cataract.MethodsInfants <7 months of age with a unilateral cataract were eligible for IATS screening. We reviewed data pertaining to the exclusion of patients as well as data collected on standardized study forms used at any time for documentation of ocular or systemic disorders.ResultsOverall, 227 infants were referred for possible enrollment. Of these, 10 had insignificant cataracts and 32 refused to participate. Of those excluded, 3 were premature, 27 had significant ocular disease (usually persistent fetal vasculature (PFV) or corneal diameter <9 mm), and 4 had systemic disorders. An additional 26 were excluded at the time of the first EUA, most often because of PFV or variants thereof. On follow-up, in the 114 enrolled patients, the following disorders were diagnosed: Stickler syndrome (1), mitochondrial disease (1), autism (1), and presumed congenital rubella syndrome (1). No patient developed a cataract in the fellow eye.DiscussionSome conditions that can feature unilateral cataracts are diagnosed at birth or very early in life, but others may be diagnosed at varying periods thereafter. PFV and its variants are the most common associated ocular findings in about a quarter of cases of unilateral congenital cataracts.ConclusionAlthough patients with a unilateral cataract may have significant associated abnormalities in the affected eye, most commonly PFV and its variants, the prevalence of associated significant systemic disease is quite low.

[Management of isolated optic neuritis in France: survey of neurologists and ophthalmologists]. / Prise en charge des névrites optiques isolées en France: enquête auprès des neurologues et des ophtalmologistes.

BACKGROUND: Acute isolated optic neuritis is often the first manifestation of multiple sclerosis (MS). Despite the results of several clinical trials its management remains controversial. With the advent of new disease-modifying agents for the treatment of MS, management of isolated optic neuritis has become more complicated. The goal of this study was to evaluate the current clinical practice of French ophthalmologists and neurologists in the management of acute isolated optic neuritis, and to evaluate the impact of recently published randomized clinical trials on their practice. METHODS: A survey, including 24 questions on the diagnosis and treatment of acute isolated optic neuritis was sent to all neurologists and to a sample of ophthalmologists in France. RESULTS: The responses of 655 neurologists and 141 ophthalmologists were analyzed. This study shows mostly that patients initially present more frequently to ophthalmologists, and are subsequently referred to neurologists. Most optic neuritis patients undergo a brain MRI and a lumbar puncture. Although most patients receive high dose intravenous steroids, up to 15% of neurologists and 21% of ophthalmologists still recommend oral prednisone (1 mg/kg per day). Steroids are often prescribed for the wrong reason, including to improve final visual acuity or decrease the risk of MS. Disease modifying agents are sometimes prescribed outside of the official French recommendations. CONCLUSION: The evidence-based guidelines are only partially followed by practitioners managing patients with acute optic neuritis.

Racial patterns in the effects of tobacco use on fetal growth.

OBJECTIVE: The aim of this study was to characterize the interaction between the effects on fetal growth of maternal smoking and race by means of race-specific growth normograms. STUDY DESIGN: A case-control study was performed on white and African American mothers who were delivered at 2 hospitals in metropolitan Atlanta between February 1993 and December 1994. The study population consisted of 621 small for gestational age infants and their mothers and 324 appropriate for gestational age infants and their mothers. Face-to-face interviews with mothers and detailed anthropometric measurements of neonates were performed. Relationships among tobacco use, race, and fetal growth were evaluated by means of multiple logistic regression. The chi(2) test of trend was performed to assess a dose-response relationship between smoking and fetal growth. RESULTS: Mothers of small for gestational age neonates were significantly more likely than control mothers to be single (52% versus 40%), to be primiparous (47% versus 37%), to have a low body mass index (26% versus 17%), to have hypertension (22% versus 15%), and to use alcohol (15% versus 9%). Mothers of small for gestational age infants were significantly more likely than control mothers to smoke (26% versus 12%) and to smoke more cigarettes (P <.05). After controlling for potential confounders cigarette smoking in the second trimester was significantly associated with small for gestational age infants in both races (whites <1 pack/d adjusted odds ratio 3.82, 1-2 packs/d adjusted odds ratio 4.86, >2 packs/d crude odds ratio; African Americans <1 pack/d adjusted odds ratio 2. 35, 1-2 packs/d adjusted odds ratio 2.52). The chi(2) test of trend results were consistent with a dose-response relationship between smoking and small for gestational age infants (whites chi(2) = 14.06, P <.0001, African Americans chi(2) = 7.99). Comparison between the 2 races of the adverse effects of smoking on fetal growth showed no significant difference. CONCLUSION: Self-reported maternal smoking during the second trimester is associated with fetal growth restriction in a dose-response manner. According to race-specific growth normograms no significant difference in the effects of tobacco use on fetal growth was found between white and African American women.